CDTX - Cidara Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$177.88
DETAILS
HIGH:
$221.50
LOW:
$150.00
MEDIAN:
$170.00
CONSENSUS:
$177.88
DOWNSIDE:
19.65%
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||
| Revenue | 1.3 | 23.3 | 64.4 | 49.6 | 12.1 | 20.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 36.8 | 0 | 73.1 | 0 | 46.4 | 0.5 | 0.7 | 0.7 | 0.5 | 0 | 0 | 0 |
| Gross Profit | 1.3 | (13.5) | 64.4 | (23.5) | 12.1 | (25.5) | (0.5) | (0.7) | (0.7) | (0.5) | 0 | 0 | 0 |
| Operating Expenses | |||||||||||||
| R&D Expenses | 156.8 | 36.8 | 77.4 | 73.1 | 68.0 | 46.4 | 49.1 | 42.8 | 35.7 | 23.5 | 6.7 | 0.8 | 0.0 |
| SG&A Expenses | 20.6 | 13.6 | 20.5 | 18.7 | 15.9 | 16.2 | 14.1 | 12.9 | 12.7 | 8.8 | 3.3 | 0.3 | 0.8 |
| Other Expenses | 0 | (36.8) | 0 | (73.1) | 0 | 0 | (0.2) | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 177.4 | 13.6 | 98.0 | 18.7 | 83.9 | 62.6 | 63.3 | 55.7 | 48.4 | 32.3 | 10.0 | 1.1 | 0.8 |
| Operating Income | |||||||||||||
| Operating Income | (176.1) | (27.1) | (33.5) | (42.3) | (71.8) | (41.7) | (63.3) | (55.7) | (48.4) | (32.3) | (11.6) | (1.1) | (0.8) |
| Interest Expense | 0 | 0 | 0 | 0 | 0.3 | 0 | 0.6 | 0.0 | 0.3 | 0.1 | 0 | 0 | 0 |
| Interest Income | 5.8 | 2.0 | 0.2 | 0 | 0 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profitability | |||||||||||||
| EBITDA | (175.9) | (26.9) | (33.4) | (42.1) | (70.8) | (41.4) | (62.8) | (55.7) | (47.7) | (31.9) | (9.8) | (1.1) | 0 |
| EBIT | (176.1) | (27.1) | (33.5) | (42.3) | (71.8) | (41.7) | (63.3) | (55.7) | (48.4) | (32.2) | (11.6) | (1.1) | 0 |
| Income Before Tax | (170.3) | (25.1) | (33.3) | (42.5) | (72.1) | (41.1) | (59.0) | (55.7) | (48.2) | (32.2) | (11.9) | (1.3) | (0.8) |
| Income Tax Expense | 0 | 0.0 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.7 | 0 | 0 |
| Net Income | (169.8) | (22.9) | (33.6) | (42.5) | (72.1) | (41.1) | (59.0) | (55.7) | (48.2) | (32.2) | (11.9) | (1.3) | (0.8) |
| Per Share Data | |||||||||||||
| EPS (Basic) | -26.75 | -5.25 | -9.61 | -16.20 | -36.03 | -26.78 | -45.62 | -63.69 | -66.49 | -46.76 | -290.15 | -83.04 | -44.70 |
| EPS (Diluted) | -26.75 | -5.25 | -9.61 | -16.19 | -36.03 | -26.78 | -45.62 | -63.69 | -66.49 | -46.76 | -290.15 | -83.04 | -0.25 |
| Shares Outstanding | 6.3 | 4.4 | 3.5 | 2.6 | 2.1 | 1.5 | 1.3 | 0.9 | 0.7 | 0.7 | 0.0 | 0.0 | 0.0 |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 189.8 | 35.8 | 32.7 | 62.3 | 35.9 | 50.3 | 74.6 | 75.3 | 104.6 | 107.5 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.7 | 16.2 | 5.8 | 5.4 | 11.2 | 0.0 | 0 | 0.3 | 0 | 0 |
| Inventory | 0 | 6.1 | 0 | (2.6) | 0 | 0 | 0 | (0.3) | 0 | 0 |
| Other Current Assets | 19.2 | 2.7 | 0 | 2.6 | 7.0 | 10 | 2.6 | 0 | 0.8 | 0.7 |
| Total Current Assets | 210.7 | 60.9 | 45.1 | 71.7 | 57.2 | 65.8 | 77.1 | 77.7 | 105.4 | 108.2 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 4.0 | 5.1 | 1.3 | 2.5 | 1.2 | 2.1 | 0.7 | 1.0 | 1.4 | 1.7 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0.1 | 1.0 | 1.1 | 0.5 | 2.0 | 1.1 | 1.3 | 0.3 | 0.2 | 0.1 |
| Total Non-Current Assets | 4.1 | 6.2 | 2.4 | 3.6 | 3.2 | 3.2 | 2.0 | 1.4 | 1.6 | 1.8 |
| Total Assets | 214.8 | 67.0 | 47.5 | 75.3 | 60.4 | 69.0 | 79.1 | 79.0 | 107.0 | 110.0 |
| Current Liabilities | ||||||||||
| Account Payables | 3.6 | 3.8 | 1.4 | 1.3 | 4.6 | 1.9 | 2.8 | 2.6 | 2.9 | 3.1 |
| Short-Term Debt | 0 | 0 | 0 | 2.6 | 7.0 | 10.0 | 9.9 | 2.7 | 0 | 0 |
| Deferred Revenue | 0 | 25.1 | 14.6 | 13.9 | 13.9 | 9.8 | 6.7 | 0 | 0 | 0 |
| Other Current Liabilities | 44.3 | 32.2 | 4.9 | 10.2 | 4.2 | 3.7 | 4.3 | 0 | 0 | 0 |
| Total Current Liabilities | 49.6 | 67.4 | 41.4 | 34.0 | 38.6 | 30.2 | 19.9 | 12.1 | 8.9 | 6.0 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.2 | 9.8 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0 | 0.1 | 0.1 |
| Total Non-Current Liabilities | 1.9 | 7.8 | 20.5 | 19.7 | 11.1 | 0.9 | 0.1 | 7.2 | 9.9 | 6.1 |
| Total Liabilities | 51.5 | 75.2 | 61.9 | 53.8 | 49.7 | 31.1 | 20.0 | 19.3 | 18.8 | 6.1 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (611.3) | (441.4) | (418.5) | (377.2) | (334.7) | (259.8) | (218.7) | (149.4) | (93.7) | (45.5) |
| Accumulated Other Comprehensive Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.0) | (0.0) | (0.0) |
| Total Stockholders' Equity | 163.3 | (8.2) | (14.4) | 21.6 | 10.7 | 37.8 | 59.1 | 59.7 | 88.2 | 103.9 |
| Total Liabilities & Equity | 214.8 | 67.0 | 47.5 | 75.3 | 60.4 | 69.0 | 79.1 | 79.0 | 107.0 | 110.0 |
| Debt Metrics | ||||||||||
| Total Debt | 3.6 | 4.9 | 1.2 | 5.1 | 8.0 | 11.7 | 9.9 | 9.9 | 9.8 | 0 |
| Net Debt | (186.2) | (30.9) | (31.5) | (57.2) | (27.9) | (38.5) | (64.6) | (65.4) | (94.8) | (107.5) |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (169.8) | (22.9) | (33.6) | (42.5) | (72.1) | (41.1) | (59.0) | (55.7) | (48.2) | (32.2) |
| Depreciation & Amortization | 0.2 | 0.1 | 0.1 | (1.2) | 0.2 | 0.4 | 0.5 | 0.7 | 0.7 | 0.5 |
| Stock-Based Compensation | 3.9 | 3.1 | 3.5 | 4.0 | 4.1 | 5.1 | 5.7 | 5.7 | 4.3 | 3.0 |
| Change in Working Capital | (13.9) | (3.9) | 0.5 | 14.4 | 13.4 | 7.5 | (0.4) | (0.6) | 3.5 | 2.7 |
| Other Non-Cash Items | 3.1 | 1.2 | 1.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.1 |
| Operating Cash Flow | (176.5) | (22.4) | (28.5) | (25.2) | (54.4) | (28.5) | (56.7) | (49.9) | (39.8) | (26.0) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.1) | (0.5) | (0.1) | (0.0) | (0.2) | (0.0) | (0.2) | (0.3) | (0.4) | (1.2) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | (14.5) | (19.5) | (69.6) | (54.9) |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 29.0 | 24.3 | 95.5 | 10 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 14.5 | 4.8 | 25.9 | (44.9) |
| Investing Cash Flow | (0.1) | (0.5) | (0.1) | (0.0) | (0.2) | (0.0) | 14.3 | 4.5 | 25.5 | (46.1) |
| Financing Activities | ||||||||||
| Net Debt Issuance | (0.3) | 0 | (2.6) | (4.4) | (3.0) | 0 | 0 | 0 | 9.9 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.0 | 0.0 | (0.7) | 0.0 | 0.0 | (0.0) | 49.7 | 0.2 | 0.5 | 0.4 |
| Financing Cash Flow | 337.1 | 26.0 | (1.0) | 44.6 | 37.3 | 14.3 | 56.2 | 20.9 | 37.1 | 111.8 |
| Cash Position | ||||||||||
| Net Change in Cash | 160.4 | 3.0 | (29.5) | 19.3 | (17.3) | (14.3) | 13.7 | (24.6) | 22.8 | 39.8 |
| Cash at Beginning | 35.8 | 32.7 | 62.3 | 42.9 | 60.3 | 74.6 | 60.8 | 85.4 | 62.6 | 22.8 |
| Cash at End | 196.2 | 35.8 | 32.7 | 62.3 | 42.9 | 60.3 | 74.6 | 60.8 | 85.4 | 62.6 |
| Free Cash Flow | (176.7) | (22.9) | (28.6) | (25.3) | (54.6) | (28.6) | (56.9) | (50.2) | (40.2) | (27.1) |
| Key Metrics | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||
| Revenue | 1.3 | 23.3 | 64.4 | 49.6 | 12.1 | 20.9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 1.3 | (13.5) | 64.4 | (23.5) | 12.1 | (25.5) | (0.5) | (0.7) | (0.7) | (0.5) | 0 | 0 | 0 |
| Operating Income | (176.1) | (27.1) | (33.5) | (42.3) | (71.8) | (41.7) | (63.3) | (55.7) | (48.4) | (32.3) | (11.6) | (1.1) | (0.8) |
| Net Income | (169.8) | (22.9) | (33.6) | (42.5) | (72.1) | (41.1) | (59.0) | (55.7) | (48.2) | (32.2) | (11.9) | (1.3) | (0.8) |
| EPS (Diluted) | -26.75 | -5.25 | -9.61 | -16.19 | -36.03 | -26.78 | -45.62 | -63.69 | -66.49 | -46.76 | -290.15 | -83.04 | -0.25 |
| Balance Sheet | |||||||||||||
| Cash & Equivalents | 189.8 | 35.8 | 32.7 | 62.3 | 35.9 | 50.3 | 74.6 | 75.3 | 104.6 | 107.5 | |||
| Total Assets | 214.8 | 67.0 | 47.5 | 75.3 | 60.4 | 69.0 | 79.1 | 79.0 | 107.0 | 110.0 | |||
| Total Debt | 3.6 | 4.9 | 1.2 | 5.1 | 8.0 | 11.7 | 9.9 | 9.9 | 9.8 | 0 | |||
| Stockholders' Equity | 163.3 | (8.2) | (14.4) | 21.6 | 10.7 | 37.8 | 59.1 | 59.7 | 88.2 | 103.9 | |||
| Cash Flow | |||||||||||||
| Operating Cash Flow | (176.5) | (22.4) | (28.5) | (25.2) | (54.4) | (28.5) | (56.7) | (49.9) | (39.8) | (26.0) | |||
| Capital Expenditure | (0.1) | (0.5) | (0.1) | (0.0) | (0.2) | (0.0) | (0.2) | (0.3) | (0.4) | (1.2) | |||
| Free Cash Flow | (176.7) | (22.9) | (28.6) | (25.3) | (54.6) | (28.6) | (56.9) | (50.2) | (40.2) | (27.1) | |||